Table 1.
Demographic information.
| COVID-19 | Control | P-value | |
|---|---|---|---|
| N | 10 | 9 | |
| Age mean (SD) | 53.6 (9.06) | 51.2 (9.15) | 0.577 |
| Number of females/males | 5F/5M | 5F/4M | 0.809 |
| BMI (kg/m2) mean (SD) | 27.94 (5.69) | 25.93 (4.34) | 0.408 |
| Number of days hospitalized mean (SD) | 13.3 (18.07) | N/A | |
| Number of symptoms mean (SD) | 5.8 (4.78) | N/A | |
| Diabetes (total # of patients) | 2 | N/A | |
| Hypertension (total # of patients) | 2 | N/A | |
| Smoker (total # of patients) | 2 | N/A | |
| Fever (total # of patients) | 3 | N/A | |
| Number of patients with mild COVID-19 | 2 | N/A | |
| Number of patients with moderate COVID-19 | 4 | N/A | |
| Number of patients with severe COVID-19 | 2 | N/A | |
| Number of patients with critical COVID-19 | 2 | N/A | |
| Days between recovery and 7T scan range (median) | 50–596 (580) | N/A |
Participant demographics and accompanying statistical measures. Group differences were assessed for significance using a two-sided T-test. For days between recovery and 7T scan, we calculated 14 days post diagnosis date for non-hospitalized patients, and for patients who were hospitalized, we calculated recovery at time of discharge from the hospital. COVID-19 severity was assessed based on imaging findings, if available, incidence of intubation, receival of supplemental oxygen, etc. along with NIH based clinical spectrum of SARS-COV-2 infection.